AVAH

Aveanna Healthcare Holdings Inc. Healthcare - Medical Care Facilities Investor Relations →

NO
194.4% ABOVE
↓ Approaching Was 207.5% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $4.64
14-Week RSI 91
Rel. Volume (14w) This week's trading vs. the 14-week average 1.9x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.05

Aveanna Healthcare Holdings Inc. (AVAH) closed at $13.67 as of 2026-09-18, trading 194.4% above its 200-week moving average of $4.64. The stock is currently moving closer to the line, down from 207.5% last week. With a 14-week RSI of 91, AVAH is in overbought territory.

Trading volume is running at 1.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.05 ratio) is neutral — neither side is clearly dominating.

Over the past 233 weeks of data, AVAH has crossed below its 200-week moving average 2 times. On average, these episodes lasted 60 weeks. Historically, investors who bought AVAH at the start of these episodes saw an average one-year return of +10.5%.

With a market cap of $3.0 billion, AVAH is a mid-cap stock. The company generates a free cash flow yield of 3.5%. Return on equity stands at 198.6%, indicating strong profitability. The stock trades at 10.4x book value.

Share count has increased 11.7% over three years, indicating dilution.

Over the past 4.5 years, a hypothetical investment of $100 in AVAH would have grown to $468, compared to $196 for the S&P 500. That represents an annualized return of 40.9% vs 16.2% for the index — confirming AVAH as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: AVAH vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After AVAH Crosses Below the Line?

Across 2 historical episodes, buying AVAH when it crossed below its 200-week moving average produced an average return of -15.5% after 12 months (median +27.0%), compared to +10.5% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was -20.0% vs +26.0% for the index.

Each line shows $100 invested at the moment AVAH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices AVAH would reach each dislocation threshold.

Current Bean Score -1.39σ
Current FCF Yield 5.31%
Baseline Yield 7.97%
Historical σ 1.00pp

Dislocation Price Levels

Prices where AVAH's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-11-05.

LevelσPriceSignal
Deep Value+2σ$8.33Unusually cheap — analysis point
Value+1σ$9.41Cheap vs. own history
Fair Value+0σ$10.82Historical mean behavior
Expensive-1σ$12.73Expensive vs. own history
Deep Expensive-2σ$15.45Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-08-13$0.17$0.22+31.6%
2026-05-14$0.13$0.18+41.9%
2026-03-19$0.16$0.17+8.7%
2025-11-06$0.13$0.15+14.9%
Data depth: 2 quarterly baselines, 24 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

13 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from AVAH's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score -2.23σ Distance from line vs own history
Sector-Relative -2.56σ Vs sector median this week
Buyback Acceleration +5.4pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +6.7pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+18.8pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

AVAH has crossed below its 200-week MA 2 times with an average 1-year return of +10.5% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 2022Jul 202412086.7%-66.7%+342.4%
Mar 2025Mar 202510.5%+87.8%+255.1%
Average60+10.5%

Frequently Asked Questions

Is AVAH below its 200-week moving average?

No. Aveanna Healthcare Holdings Inc. (AVAH) is currently 194.4% above its 200-week moving average of $4.64. It would need to fall to $4.64 to cross below the line.

What is AVAH's 200-week moving average price?

Aveanna Healthcare Holdings Inc.'s 200-week moving average is $4.64 as of 2026-09-18. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when AVAH drops below its 200-week moving average?

AVAH has crossed below its 200-week moving average 2 times in our data. On average, buying at that moment produced a one-year return of +10.5%. These dips have historically been decent entry points. These episodes lasted 60 weeks on average.

Is AVAH a good value right now?

Here's what our data says about AVAH as of 2026-09-18: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 91 (overbought). Free cash flow yield is 3.5%. Return on equity is 198.6%. Price-to-book is 10.4x. This is not a buy or sell recommendation — always do your own research.

How does AVAH compare to the S&P 500?

Over the past 4.5 years, $100 invested in AVAH would have grown to $468, compared to $196 for the S&P 500. That's 40.9% annualized vs 16.2% for the index. AVAH has outperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-09-18